Solarvest Bioenergy Inc. Announces New CFO and Corporate Update Zoom Meeting for Solarvest Shareholders
Vancouver, BC - TheNewswire - January 31, 2023 - Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS), announces that Leslie Auld has been appointed the company’s Chief Financial Officer effective January 30, 2023.
Leslie Auld is a seasoned Financial Executive with over 30 years of relevant experience, including a background in Canadian and U.S. publicly listed companies in the pharmaceutical and diagnostic technology industries. She has held executive positions in biotechnology companies including Aeterna Zentaris and most recently as CFO of Tetra Bio-Pharma.
Ms. Auld is an experienced financial executive with extensive biotech experience. She is a CPA in Canada and holds a H. BSc., in Pharmacology and Toxicology from Western University and an MBA from the University of Toronto – Rotman School of Management.
Claes Ellegaard, CEO of Solarvest says “Leslie is an analytical, strategic, and solutions-oriented finance professional, who will bring a lot of expertise and experience to our organization and I’m very pleased that Leslie will join our team.”
Mr. Ellegaard continues “Leslie will work hand-in-hand with Gerard Watts, who up till now has been acting as Solarvest’s interim CFO. We are very grateful that Gerard will continue being part of the organization in this important transition phase where his experience will be invaluable”.
Solarvest invite all shareholders to a corporate update meeting hosted on Zoom Wednesday February 8, 2023 at 4.15 pm EST. Please use following zoom link to participate in the call: https://zoom.us/j/92930790470
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins.
For further information contact:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the terms of the Offering, the completion of the Offering and the expected use of the net proceeds received by the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; and regulatory risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement. The Company does not undertake to update any forward-looking information, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
None of the securities of Solarvest have been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law, and may not be offered or sold in the United States or to, or for the account or benefit of, persons in the United States or “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act) absent registration or an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy in the United States nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.